Influence of single-nucleotide polymorphisms in TLR3 (rs3775291) and TLR9 (rs352139) on the risk of CMV infection in kidney transplant recipients
Risk stratification for cytomegalovirus (CMV) infection after kidney transplantation (KT) remains to be determined. Since endosomal toll-like receptors (TLRs) are involved in viral sensing, we investigated the impact of common single-nucleotide polymorphisms (SNPs) located within TLR3 and TLR9 genes on the occurrence of overall and high-level (≥1,000 IU/ml) CMV infection in a cohort of 197 KT recipients. Homozygous carriers of the minor allele of TLR3 (rs3775291) had higher infection-free survival compared with reference allele carriers (60.0% for TT versus 42.3% for CC/CT genotypes; P-value = 0.050). Decreased infection-free survival was observed with the minor allele of TLR9 (rs352139) (38.2% for TC/CC versus 59.3% for TT genotypes; P-value = 0.004). After multivariable adjustment, the recessive protective effect of the TLR3 (rs3775291) TT genotype was confirmed (adjusted hazard ratio [aHR]: 0.327; 95% CI: 0.167–0.642; P-value = 0.001), as was the dominant risk-conferring effect of TLR9 (rs352139) TC/CC genotypes (aHR: 1.865; 95% CI: 1.170–2.972; P-value = 0.009). Carriers of the TLR9 (rs352139) TC/CC genotypes showed lower CMV-specific interferon-γ-producing CD4+ T-cell counts measured by intracellular cytokine staining compared with the TT genotype (median of 0.2 versus 0.7 cells/μl; P-value = 0.003). In conclusion, TLR3/TLR9 genotyping may inform CMV infection risk after KT..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Frontiers in Immunology - 13(2022) |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Natalia Redondo [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Cytomegalovirus |
|---|
| doi: |
10.3389/fimmu.2022.929995 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ032934319 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ032934319 | ||
| 003 | DE-627 | ||
| 005 | 20230307173205.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fimmu.2022.929995 |2 doi | |
| 035 | |a (DE-627)DOAJ032934319 | ||
| 035 | |a (DE-599)DOAJ20d59e8abc194317a5988d715b2f389a | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC581-607 | |
| 100 | 0 | |a Natalia Redondo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Influence of single-nucleotide polymorphisms in TLR3 (rs3775291) and TLR9 (rs352139) on the risk of CMV infection in kidney transplant recipients |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Risk stratification for cytomegalovirus (CMV) infection after kidney transplantation (KT) remains to be determined. Since endosomal toll-like receptors (TLRs) are involved in viral sensing, we investigated the impact of common single-nucleotide polymorphisms (SNPs) located within TLR3 and TLR9 genes on the occurrence of overall and high-level (≥1,000 IU/ml) CMV infection in a cohort of 197 KT recipients. Homozygous carriers of the minor allele of TLR3 (rs3775291) had higher infection-free survival compared with reference allele carriers (60.0% for TT versus 42.3% for CC/CT genotypes; P-value = 0.050). Decreased infection-free survival was observed with the minor allele of TLR9 (rs352139) (38.2% for TC/CC versus 59.3% for TT genotypes; P-value = 0.004). After multivariable adjustment, the recessive protective effect of the TLR3 (rs3775291) TT genotype was confirmed (adjusted hazard ratio [aHR]: 0.327; 95% CI: 0.167–0.642; P-value = 0.001), as was the dominant risk-conferring effect of TLR9 (rs352139) TC/CC genotypes (aHR: 1.865; 95% CI: 1.170–2.972; P-value = 0.009). Carriers of the TLR9 (rs352139) TC/CC genotypes showed lower CMV-specific interferon-γ-producing CD4+ T-cell counts measured by intracellular cytokine staining compared with the TT genotype (median of 0.2 versus 0.7 cells/μl; P-value = 0.003). In conclusion, TLR3/TLR9 genotyping may inform CMV infection risk after KT. | ||
| 650 | 4 | |a cytomegalovirus | |
| 650 | 4 | |a kidney transplantation | |
| 650 | 4 | |a single-nucleotide polymorphism (SNP) | |
| 650 | 4 | |a toll-like receptor 3 (TLR3) | |
| 650 | 4 | |a toll-like receptor 9 (TLR9) | |
| 653 | 0 | |a Immunologic diseases. Allergy | |
| 700 | 0 | |a Natalia Redondo |e verfasserin |4 aut | |
| 700 | 0 | |a Isabel Rodríguez-Goncer |e verfasserin |4 aut | |
| 700 | 0 | |a Isabel Rodríguez-Goncer |e verfasserin |4 aut | |
| 700 | 0 | |a Patricia Parra |e verfasserin |4 aut | |
| 700 | 0 | |a Patricia Parra |e verfasserin |4 aut | |
| 700 | 0 | |a Tamara Ruiz-Merlo |e verfasserin |4 aut | |
| 700 | 0 | |a Tamara Ruiz-Merlo |e verfasserin |4 aut | |
| 700 | 0 | |a Francisco López-Medrano |e verfasserin |4 aut | |
| 700 | 0 | |a Francisco López-Medrano |e verfasserin |4 aut | |
| 700 | 0 | |a Francisco López-Medrano |e verfasserin |4 aut | |
| 700 | 0 | |a Esther González |e verfasserin |4 aut | |
| 700 | 0 | |a Natalia Polanco |e verfasserin |4 aut | |
| 700 | 0 | |a Hernando Trujillo |e verfasserin |4 aut | |
| 700 | 0 | |a Ana Hernández |e verfasserin |4 aut | |
| 700 | 0 | |a Rafael San Juan |e verfasserin |4 aut | |
| 700 | 0 | |a Rafael San Juan |e verfasserin |4 aut | |
| 700 | 0 | |a Rafael San Juan |e verfasserin |4 aut | |
| 700 | 0 | |a Amado Andrés |e verfasserin |4 aut | |
| 700 | 0 | |a Amado Andrés |e verfasserin |4 aut | |
| 700 | 0 | |a José María Aguado |e verfasserin |4 aut | |
| 700 | 0 | |a José María Aguado |e verfasserin |4 aut | |
| 700 | 0 | |a José María Aguado |e verfasserin |4 aut | |
| 700 | 0 | |a Mario Fernández-Ruiz |e verfasserin |4 aut | |
| 700 | 0 | |a Mario Fernández-Ruiz |e verfasserin |4 aut | |
| 700 | 0 | |a Mario Fernández-Ruiz |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Frontiers in Immunology |d Frontiers Media S.A., 2011 |g 13(2022) |w (DE-627)DOAJ000031690 |x 16643224 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2022 |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fimmu.2022.929995 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/20d59e8abc194317a5988d715b2f389a |z kostenfrei |
| 856 | 4 | 0 | |u https://www.frontiersin.org/articles/10.3389/fimmu.2022.929995/full |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1664-3224 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2022 | ||